4381664
iTRAQ® Reagent - Multiplex Buffer Kit
Sinonimo/i:
isobaric tags for relative and absolute quantitation, buffer kit
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Scegli un formato
1 KIT
CHF 484.00
Scegli un formato
Cambia visualizzazione
1 KIT
CHF 484.00
About This Item
Codice UNSPSC:
12161503
NACRES:
NA.25
Prodotti consigliati
Condizioni di spedizione
dry ice
Temperatura di conservazione
−20°C
Descrizione generale
Contains SDS – Denaturant, TCEP Reducing Reagent, MMTS Cysteine Blocking Reagent, TEAB Buffer and Isopropanol, sufficient material for either two 8-plex Multiplex Kits, three 4-plex Kits, or four mTRAQ® 10 Assay Kits.
The iTRAQ® Reagents are a set of isobaric, multiplexed, amine-specific, stable-isotope reagents that can label all peptides[1] in up to eight different biological samples at the same time, allowing for simultaneous identification and quantitation, both relative and absolute, while preserving important post-translational modification (PTM) information. The iTRAQ® reagents can be used to study the differential expression of proteins in perturbed systems.[1]
Applicazioni
Risultati analitici
To view the Chemistry Quick Reference Card for the iTRAQ® Reagents, please visit this Chemistry Quick Reference Card link.
Note legali
MTraq is a registered trademark of AB Sciex Pte. Ltd.
iTraq is a registered trademark of AB Sciex Pte. Ltd.
Avvertenze
Danger
Indicazioni di pericolo
Consigli di prudenza
Classi di pericolo
Eye Irrit. 2 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3
Organi bersaglio
Central nervous system
Codice della classe di stoccaggio
3 - Flammable liquids
Punto d’infiammabilità (°F)
53.6 °F - closed cup
Punto d’infiammabilità (°C)
12.0 °C - closed cup
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
I clienti hanno visto anche
Hongmei Lu et al.
Clinical proteomics, 16, 33-33 (2019-08-07)
Diabetic nephropathy is the most frequent cause of end-stage renal disease worldwide. Identification of biomarkers for diabetic nephropathy for early diagnosis may be the key to avoiding damage from this condition. Proteomic iTRAQ technology was first used to identify differentially
Lynn R Zieske
Journal of experimental botany, 57(7), 1501-1508 (2006-04-01)
Proteomic research includes the characterization of protein mixtures in order to understand complex biological systems and determine relationships between proteins, their function, and protein-protein interactions. Often the goal of such research is to monitor changes of proteins in perturbed systems
Xiangyu Deng et al.
MicrobiologyOpen, 9(5), e1012-e1012 (2020-02-29)
β-Glucosidase production by Aspergillus niger is accompanied by an inevitable temperature increase in the industrial fermentation environment. Hence, the synthetic process of β-glucosidase is negatively affected. However, our understanding of the heat stress response (HSR) mechanism in A. niger is still
Juan Du et al.
FEBS letters, 592(22), 3736-3749 (2018-10-13)
Circadian clocks control daily rhythms in physiology, metabolism and behaviour in most organisms. Proteome-wide analysis of protein oscillations is still lacking in Drosophila. In this study, the total protein and phosphorylated protein in Drosophila heads in a 24-h daily time-course
Kening Li et al.
Evidence-based complementary and alternative medicine : eCAM, 2019, 5107198-5107198 (2019-06-22)
NaoMaiTong (NMT) is widely used in the treatment of cerebral ischemia but the molecular details of its beneficial effects remain poorly characterized. In this study, we used iTRAQ using 2D LC-MS/MS technology to investigate the cellular mechanisms governing the protective
Active Filters
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.
